Trial Profile
Effectiveness of Lactobacillus Reuteri DSM17938 Supplementation on Crying Time in Infantile Colic
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 17 May 2022
Price :
$35
*
At a glance
- Drugs Limosilactobacillus reuteri (Primary)
- Indications Colic
- Focus Therapeutic Use
- Sponsors BioGaia
- 02 May 2022 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 12 Apr 2017 New trial record